Study to Review Clinical and Imaging Data for Bone Metastases from Carcinoma in Adults

What this Trial Is About

Researchers are reviewing medical records, radiological images, and histological data of approximately 750 patients treated for bone metastases from carcinoma at the Rizzoli Orthopaedic Institute between January 1, 2010, and December 31, 2022. This observational study aims to generate synthetic patient data to evaluate fracture risk related to bone metastases from various carcinomas. The study involves analyzing and reviewing existing clinical and imaging data from these patients without administering new treatments. It focuses on patients diagnosed with bone metastases regardless of carcinoma type, number, or location of metastases. The primary goal is to create a comprehensive dataset of clinical information and diagnostic images collected at baseline. Participants involvement consists of data review and analysis based on available records and follow-up information from the last 12 months after diagnosis. Researchers will measure outcomes by compiling this dataset for risk evaluation. Since this is a retrospective observational study, no direct interventions or additional visits are required from participants. The study is expected to continue through December 2026.

Fracture Risk Evaluation of Bone Metastases Derived From Carcinoma